rituximab,temelimab 
GeNeuro,Biogen,Roche
['ritux', 'imab ']
piehl: add-on with temelimab (anti-hrev-w = antiviral) on top of rituximab to look at neuroprotection. (protect-ms trial). first safety results are reassuring. clinically at 12mths no real signals, on mri and csf gfap/nfl some positive trend on exploratory endpoints
#ectrims2022
Professor Dr Bart Van Wijmeersch
Neurologist, Immunologist
#MultipleSclerosis Expert
@ University MS Centre, Hasselt-Pelt, Belgium